Reply to "Double-carbapenem therapy not proven to be more active than carbapenem monotherapy against KPC-positive Klebsiella pneumoniae"

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 4038-

  Bulik, Catharine C ^a   Nicolau, David P ^b  

^a INSTITUTE FOR CLINICAL PHARMACODYNAMICS   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; DORIPENEM; ERTAPENEM;

BACTERIAL GROWTH; COMBINATION CHEMOTHERAPY; GROWTH REGULATION; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL;

EID: 84862573770     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00347-12     Document Type: Letter

References (1)

1. Bulik CC, Nicolau DP. 2011. Double-carbapenem therapy for carbapenemase- producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 55:3002-3004.